Immuno-genomic-radiomics to predict response of biliary tract cancer to camrelizumab plus GEMOX in a single-arm phase II trial
JHEP Reports（2023）
摘要
analysis of NCT03486678.
更多查看译文
关键词
Biliary duct cancer,Radiomics,Immunotherapy,Prognosis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要